127 related articles for article (PubMed ID: 25470586)
41. Adopting more systematic approaches to hepatitis C treatment in correctional facilities.
Hammett TM
Ann Intern Med; 2003 Feb; 138(3):235-6. PubMed ID: 12558365
[No Abstract] [Full Text] [Related]
42. Accessing the cure: helping patients with hepatitis C overcome barriers to care.
Rodriguez C; Reynolds A
Am J Manag Care; 2016 Mar; 22(4 Suppl):s108-12. PubMed ID: 27270155
[TBL] [Abstract][Full Text] [Related]
43. Medical resource utilisation and healthcare costs in patients with chronic hepatitis C viral infection and thrombocytopenia.
Poordad F; Theodore D; Sullivan J; Grotzinger K
J Med Econ; 2011; 14(2):194-206. PubMed ID: 21348807
[TBL] [Abstract][Full Text] [Related]
44. [The irreversibility of cirrhosis: "the jostle dogma"].
Fartoux L; Pol S; Serfaty L
Rev Prat; 2005 Sep; 55(14):1549-51. PubMed ID: 16255296
[No Abstract] [Full Text] [Related]
45. Management of cirrhosis due to chronic hepatitis C.
Everson GT
J Hepatol; 2005; 42 Suppl(1):S65-74. PubMed ID: 15777574
[No Abstract] [Full Text] [Related]
46. Hepatitis C Virus Treatment and Injection Drug Users: It Is Time to Separate Fact From Fiction.
McCance-Katz EF; Valdiserri RO
Ann Intern Med; 2015 Aug; 163(3):224-5. PubMed ID: 26120801
[No Abstract] [Full Text] [Related]
47. Chronic viral hepatitis.
Dakhil N; Junaidi O; Befeler AS
Mo Med; 2009; 106(5):361-5. PubMed ID: 19902718
[TBL] [Abstract][Full Text] [Related]
48. Hepatitis C Treatment in Prisons - Incarcerated People's Uncertain Right to Direct-Acting Antiviral Therapy.
Daniels AM; Studdert DM
N Engl J Med; 2020 Aug; 383(7):611-613. PubMed ID: 32786186
[No Abstract] [Full Text] [Related]
49. Newest Treatments for Hepatitis C: How Can We Manage Sustainability?
Messori A
Clin Infect Dis; 2015 Dec; 61(12):1891-2. PubMed ID: 26261204
[No Abstract] [Full Text] [Related]
50. [Access to hepatitis C treatment: a lesson for the future.].
Craxì L
Recenti Prog Med; 2018 Jan; 109(1):25-27. PubMed ID: 29451518
[TBL] [Abstract][Full Text] [Related]
51. Combination therapy in naive patients with chronic hepatitis C: more value for the money.
Koff RS
J Hepatol; 2000 Oct; 33(4):664-6. PubMed ID: 11059875
[No Abstract] [Full Text] [Related]
52. Outcomes of HCV treatment: who does well and who does not?
Hsu CS; Kao JH
J Gastroenterol Hepatol; 2010 May; 25(5):846-8. PubMed ID: 20546434
[No Abstract] [Full Text] [Related]
53. Is there sufficient evidence to recommend antiviral therapy in hepatitis C?
van der Meer AJ; Wedemeyer H; Feld JJ; Hansen BE; Manns MP; Zeuzem S; Janssen HL
J Hepatol; 2014 Jan; 60(1):191-6. PubMed ID: 23973931
[TBL] [Abstract][Full Text] [Related]
54. Treating Hepatitis C.
Grennan D
JAMA; 2018 Dec; 320(21):2280. PubMed ID: 30512101
[No Abstract] [Full Text] [Related]
55. [Chronic hepatitis C virus infection: always treat!--Pro].
Zeuzem S
Dtsch Med Wochenschr; 2002 Sep; 127(36):1840. PubMed ID: 12215931
[No Abstract] [Full Text] [Related]
56. Reply to Messori.
Rein DB
Clin Infect Dis; 2015 Dec; 61(12):1892-3. PubMed ID: 26261202
[No Abstract] [Full Text] [Related]
57. Hepatitis C: tackling the silent epidemic.
Hamlyn AN
Br J Hosp Med (Lond); 2005 Oct; 66(10):579-82. PubMed ID: 16255265
[TBL] [Abstract][Full Text] [Related]
58. [Cost-effectiveness analysis of the treatment of chronic hepatitis C].
Joliot E; Vanlemmens C; Kerleau M; Le Gales C; Woronoff-Lemsi MC; Flori YA; Seror V; Hrusovsky S; Monnet E; Bresson-Hadni S; Miguet JP
Gastroenterol Clin Biol; 1996; 20(11):958-67. PubMed ID: 9119185
[TBL] [Abstract][Full Text] [Related]
59. Sticker shock and the price of new therapies for hepatitis C: is it worth it?
Reau NS; Jensen DM
Hepatology; 2014 Apr; 59(4):1246-9. PubMed ID: 24493069
[No Abstract] [Full Text] [Related]
60. What does it mean to put new hepatitis C drugs on a list of essential medicines?
Urrutia J; Porteny T; Daniels N
BMJ; 2016 Apr; 353():i2035. PubMed ID: 27106956
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
